Recordati Industria Chimica e Farmaceutica S.p.A.

General ticker "RCDTF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $12.3B (TTM average)

Recordati Industria Chimica e Farmaceutica S.p.A. follows the US Stock Market performance with the rate: 30.1%.

Estimated limits based on current volatility of 0.0%: low 56.95$, high 56.95$

Factors to consider:

  • Company pays dividends (semi-annually): last record date 2025-11-25, amount 0.73$ (Y2.56%)
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [43.68$, 61.68$]
  • 2025-12-31 to 2026-12-31 estimated range: [48.36$, 67.36$]

Financial Metrics affecting the RCDTF estimates:

  • Negative: with PPE of 19.9 at the end of fiscal year the price was high
  • Positive: Operating profit margin, % of 27.28 > 18.38
  • Positive: Industry earnings per price (median), % of 5.35 > 4.49
  • Positive: 5.46 < Industry operating cash flow per share per price (median), % of 8.11
  • Positive: Industry inventory ratio change (median), % of -0.17 <= -0.16
  • Negative: 0.73 < Interest expense per share per price, % of 0.77
  • Positive: 0.01 < Operating cash flow per share per price, % of 5.40

Similar symbols

Short-term RCDTF quotes

Long-term RCDTF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €1,853.31MM €2,082.33MM €2,341.56MM
Operating Expenses €1,415.98MM €1,524.32MM €1,702.70MM
Operating Income €437.33MM €558.01MM €638.86MM
Non-Operating Income €-35.89MM €-66.97MM €-91.67MM
Interest Expense €34.45MM €74.86MM €81.55MM
R&D Expense €220.10MM €255.75MM €286.03MM
Income(Loss) €401.44MM €491.04MM €547.18MM
Taxes €89.10MM €101.82MM €130.68MM
Profit(Loss)* €312.34MM €389.21MM €416.51MM
Stockholders Equity €1,546.25MM €1,686.39MM €1,876.81MM
Inventory €424.08MM €404.83MM €506.45MM
Assets €3,998.82MM €4,208.13MM €5,134.45MM
Operating Cash Flow €461.69MM €485.32MM €569.92MM
Capital expenditure €96.34MM €383.26MM €851.16MM
Investing Cash Flow €-767.12MM €-379.62MM €-844.94MM
Financing Cash Flow €341.28MM €-168.91MM €372.11MM
Earnings Per Share** €1.52 €1.86 €2.02

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.